Contractor
ORGANON LLC
- UEI
- QTT6LXC3YKE9
- Parent UEI
- R6PBPDWXY8Y4
- Resolved by
- uei
- Confidence
- 1.000
Active from Jan 10, 2022 to Sep 10, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79724D0015 ADALIMUMAB GROUP I, LINE ITEMS 1 AND 2 AND GROUP II LINE ITEMS 1 AND 2. AWARDED FOR A BASE YEAR OF 3/9/2024 TO 3/8/2025 PLUS FOUR ONE YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Jan 9, 2024 | — |
| 36E79723D0022 NEW AWARD FOR RENFLEXIS (INFLIXIMAB-ABDA) 100MG VIAL WITH ORGANON LLC. ORDERING PERIOD IS SEPTEMBER 1, 2023 TO AUGUST 31, 2024 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | May 3, 2023 | — |
| 36F79722D0065 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Jan 10, 2022 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier QTT6LXC3YKE9, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.